{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T18:35:26Z","timestamp":1777228526404,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,26]]},"DOI":"10.7759\/cureus.107749","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T18:00:18Z","timestamp":1777226418000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Large B-cell Lymphoma at the Base of the Tongue: A Rare Diagnostic Entity in Imaging"],"prefix":"10.7759","author":[{"given":"Soufiane","family":"Bigi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Adnor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakaria","family":"Chahbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajar","family":"El Agouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soukaina","family":"Wakrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Non-Hodgkin B-cell Lymphoma With Mandibular Involvement: A Clinical Case Report [Article in French]","author":"Cossecq CC","year":"2018","unstructured":"Cossecq CC. Non-Hodgkin B-cell Lymphoma With Mandibular Involvement: A Clinical Case Report [Article in French]. University of Bordeaux, Bordeaux, France; 2018."},{"key":"ref2","unstructured":"WHO classification of tumours of haematopoietic and lymphoid tissues. (2017). Accessed. April 23, 2026: https:\/\/www.iarc.who.int\/news-events\/who-classification-of-tumours-of-haematopoietic-and-lymphoid-tissues-2\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2002.0218","article-title":"Treatment of extranodal lymphomas","volume":"15","author":"Zucca E","year":"2002","unstructured":"Zucca E, Conconi A, Cavalli F. Treatment of extranodal lymphomas. Best Pract Res Clin Haematol. 2002, 15:533-47. 10.1053\/beha.2002.0218","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1051\/aos\/2017053","article-title":"Non-Hodgkin lymphoma B-cell primary of the oral cavity: about a clinical case [Article in French]","volume":"3","author":"Farouk M","year":"2017","unstructured":"Farouk M, Kissi L, Ben Yahya I. Non-Hodgkin lymphoma B-cell primary of the oral cavity: about a clinical case [Article in French]. Actual Odonto Stomatol. 2017, 3:1-5. 10.1051\/aos\/2017053","journal-title":"Actual Odonto Stomatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.11604\/pamj-cm.2020.4.121.26731","article-title":"Primary large B-cell non-Hodgkin lymphoma of the tongue: a very rare localization [Article in French]","volume":"4","author":"Mechtoune M","year":"2020","unstructured":"Mechtoune M, Tissir R, Tazi I. Primary large B-cell non-Hodgkin lymphoma of the tongue: a very rare localization [Article in French]. PAMJ Clin Med. 2020, 4:0. 10.11604\/pamj-cm.2020.4.121.26731","journal-title":"PAMJ Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1024\/1661-8157\/a002237","article-title":"Lymphomas [Article in French]","volume":"105","author":"Lohri A","year":"2016","unstructured":"Lohri A. Lymphomas [Article in French]. Praxis (Bern 1994). 2016, 105:47-52. 10.1024\/1661-8157\/a002237","journal-title":"Praxis (Bern 1994)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.11.026","article-title":"Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning","volume":"15","author":"Kasamon YL","year":"2009","unstructured":"Kasamon YL, Wahl RL, Ziessman HA, et al.. Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning. Biol Blood Marrow Transplant. 2009, 15:242-8. 10.1016\/j.bbmt.2008.11.026","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington SF","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, et al.. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014, 32:3048-58. 10.1200\/JCO.2013.53.5229","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.4036","article-title":"Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography-staged treatment-naive patients with Hodgkin lymphoma","volume":"30","author":"El-Galaly TC","year":"2012","unstructured":"El-Galaly TC, d'Amore F, Mylam KJ, et al.. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. J Clin Oncol. 2012, 30:4508-14. 10.1200\/JCO.2012.42.4036","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier B","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E, et al.. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood. 2010, 116:2040-5. 10.1182\/blood-2010-03-276246","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25278","article-title":"Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma","volume":"116","author":"Abramson JS","year":"2010","unstructured":"Abramson JS, Hellmann M, Barnes JA, et al.. Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Cancer. 2010, 116:4283-90. 10.1002\/cncr.25278","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425038-diffuse-large-b-cell-lymphoma-at-the-base-of-the-tongue-a-rare-diagnostic-entity-in-imaging","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T18:00:19Z","timestamp":1777226419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425038-diffuse-large-b-cell-lymphoma-at-the-base-of-the-tongue-a-rare-diagnostic-entity-in-imaging"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.107749","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,26]]}}}